|
2 Companies |
|
3 Products |
|
3 Products |
|
3 Mechanisms of Action |
|
0 Trials |
|
32 News |
|
- | NN1213 / Novo Nordisk
Trial completion, Trial primary completion date: Assessment of CMV-specific ELISPOT Assay for Predicting CMV Co-infection in Patients With Pneumocystitis Pneumonia (ACE-PCP) (clinicaltrials.gov) - Aug 29, 2018
P=N/A, N=76, Completed, Sponsor: Asan Medical Center
Recruiting --> Completed | Trial primary completion date: Dec 2016 --> Dec 2015
- ||| Trial completion, Enrollment change, Trial primary completion date: Clinical Impact of Fungal Domestic Environmental Exposure on COPD Patients (clinicaltrials.gov) - Dec 22, 2017
P=N/A, N=65, Completed, Sponsor: University Hospital, Lille
Recruiting --> Completed | Trial primary completion date: Dec 2016 --> Dec 2015 Recruiting --> Completed | N=90 --> 65 | Trial primary completion date: May 2017 --> Oct 2017
- | trimethoprim/sulfamethoxazole / Generic mfg.
Enrollment change, Trial initiation date, Trial termination, Trial primary completion date: TriSulfa-FPI: Study to Test the Validity of the Treatment of Idiopathic Pulmonary Fibrosis With Cotrimoxazole (clinicaltrials.gov) - Nov 14, 2017
P3, N=3, Terminated, Sponsor: Fundaci
Recruiting --> Completed | N=90 --> 65 | Trial primary completion date: May 2017 --> Oct 2017 N=56 --> 3 | Initiation date: Jun 2013 --> Nov 2013 | Recruiting --> Terminated | Trial primary completion date: May 2016 --> Nov 2015; Changes in standards of care
- Trial completion, Enrollment change: MACS: Prevalence and Pathogenesis of Lung Disease in a Large HIV Cohort-coordinating Center (clinicaltrials.gov) - Oct 26, 2016
P=N/A, N=407, Completed, Sponsor: University of Pittsburgh
N=56 --> 3 | Initiation date: Jun 2013 --> Nov 2013 | Recruiting --> Terminated | Trial primary completion date: May 2016 --> Nov 2015; Changes in standards of care Active, not recruiting --> Completed | N=600 --> 407
- Trial completion, Enrollment change: PCP-CMV: Prevalence of Pneumocystis Jirovecii and of Cytomegalovirus in Bronchial Wash Fluid of Patients Undergoing Bronchoscopy (clinicaltrials.gov) - Jul 28, 2016
P=N/A, N=93, Completed, Sponsor: Carmel Medical Center
Active, not recruiting --> Completed | N=600 --> 407 Recruiting --> Completed | N=300 --> 93
- Enrollment change, Trial primary completion date: Assessment of CMV-specific ELISPOT Assay for Predicting CMV Co-infection in Patients With Pneumocystitis Pneumonia (ACE-PCP) (clinicaltrials.gov) - Feb 8, 2016
P=N/A, N=100, Recruiting, Sponsor: Asan Medical Center
Recruiting --> Completed | N=300 --> 93 N=80 --> 100 | Trial primary completion date: Dec 2015 --> Dec 2016
- prednisone / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date: Pneumocystis Jerovici Pneumonia in Infants and Steroids (clinicaltrials.gov) - Dec 11, 2015
P=N/A, N=78, Completed, Sponsor: University of Malawi College of Medicine
N=80 --> 100 | Trial primary completion date: Dec 2015 --> Dec 2016 Recruiting --> Completed | N=200 --> 78 | Trial primary completion date: Dec 2014 --> Aug 2014
- Enrollment change, Trial primary completion date: Assessment of CMV-specific ELISPOT Assay for Predicting CMV Co-infection in Patients With Pneumocystitis Pneumonia (ACE-PCP) (clinicaltrials.gov) - Aug 28, 2015
P=N/A, N=80, Recruiting, Sponsor: Asan Medical Center
Recruiting --> Completed | N=200 --> 78 | Trial primary completion date: Dec 2014 --> Aug 2014 N=30 --> 80 | Trial primary completion date: May 2015 --> Dec 2015
- || Trial primary completion date: Clinical Impact of Fungal Domestic Environmental Exposure on COPD Patients (clinicaltrials.gov) - Jun 18, 2015
P=N/A, N=90, Recruiting, Sponsor: University Hospital, Lille
N=30 --> 80 | Trial primary completion date: May 2015 --> Dec 2015 Trial primary completion date: Feb 2015 --> May 2017
- ||| Clinical: Clinical Impact of Fungal Domestic Environmental Exposure on COPD Patients (clinicaltrials.gov) - Dec 19, 2014
P=N/A, N=90, Recruiting, Sponsor: University Hospital, Lille
- Enrollment closed: MACS: Prevalence and Pathogenesis of Lung Disease in a Large HIV Cohort-coordinating Center (clinicaltrials.gov) - Sep 5, 2014
P=N/A, N=600, Active, not recruiting, Sponsor: University of Pittsburgh
Trial primary completion date: Feb 2015 --> May 2017 Recruiting --> Active, not recruiting
- Trial primary completion date: Assessment of CMV-specific ELISPOT Assay for Predicting CMV Co-infection in Patients With Pneumocystitis Pneumonia (ACE-PCP) (clinicaltrials.gov) - Jun 13, 2014
P=N/A, N=30, Recruiting, Sponsor: Asan Medical Center
Recruiting --> Active, not recruiting Trial primary completion date: Jan 2015 --> May 2015
- Enrollment open: Assessment of CMV-specific ELISPOT Assay for Predicting CMV Co-infection in Patients With Pneumocystitis Pneumonia (ACE-PCP) (clinicaltrials.gov) - Jun 13, 2014
P=N/A, N=30, Recruiting, Sponsor: Asan Medical Center
Trial primary completion date: Jan 2015 --> May 2015 Not yet recruiting --> Recruiting
- Clinical: Assessment of CMV-specific ELISPOT Assay for Predicting CMV Co-infection in Patients With Pneumocystitis Pneumonia (ACE-PCP) (clinicaltrials.gov) - Apr 8, 2014
P=N/A, N=30, Not yet recruiting, Sponsor: Asan Medical Center
- Enrollment change: Antiretroviral Drug Interaction Study in Volunteers With HIV (clinicaltrials.gov) - Feb 20, 2014
P1, N=32, Completed, Sponsor: National Institutes of Health Clinical Center (CC)
Not yet recruiting --> Recruiting N=100 --> 32
- Trial completion: Antiretroviral Drug Interaction Study in Volunteers With HIV (clinicaltrials.gov) - Feb 20, 2014
P1, N=32, Completed, Sponsor: National Institutes of Health Clinical Center (CC)
N=100 --> 32 Recruiting --> Completed
- | Neutrexin (trimetrexate) / Pfizer
Trial completion: A Treatment Protocol for the Use of Trimetrexate With Leucovorin Rescue for AIDS Patients With Pneumocystis Carinii Pneumonia and Serious Intolerance to Approved Therapies (clinicaltrials.gov) - Feb 19, 2014
P3, N=0, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting --> Completed Active, not recruiting --> Completed
- | trimethoprim/sulfamethoxazole / Generic mfg.
Trial initiation date: TriSulfa-FPI: Study to Test the Validity of the Treatment of Idiopathic Pulmonary Fibrosis With Cotrimoxazole (clinicaltrials.gov) - Feb 2, 2014
P3, N=56, Recruiting, Sponsor: Fundaci
Active, not recruiting --> Completed Initiation date: Mar 2013 --> Jun 2013
- | trimethoprim/sulfamethoxazole / Generic mfg.
Enrollment open: TriSulfa-FPI: Study to Test the Validity of the Treatment of Idiopathic Pulmonary Fibrosis With Cotrimoxazole (clinicaltrials.gov) - Feb 2, 2014
P3, N=56, Recruiting, Sponsor: Fundaci
Initiation date: Mar 2013 --> Jun 2013 Not yet recruiting --> Recruiting
- Trial withdrawal: Corticosteroids Therapy and Pneumocystis Jirovecii Pneumonia (PCP) (clinicaltrials.gov) - Aug 19, 2013
P4, N=0, Withdrawn, Sponsor: George Washington University
Not yet recruiting --> Recruiting Recruiting --> Withdrawn
- Enrollment change: Corticosteroids Therapy and Pneumocystis Jirovecii Pneumonia (PCP) (clinicaltrials.gov) - Aug 19, 2013
P4, N=0, Withdrawn, Sponsor: George Washington University
Recruiting --> Withdrawn N=54 --> 0
- trimethoprim/sulfamethoxazole / Generic mfg.
Trial termination: DB289 Versus TMP-SMX for the Treatment of Acute Pneumocystis Jiroveci Pneumonia (PCP) (clinicaltrials.gov) - Mar 5, 2013
P3, N=48, Terminated, Sponsor: Immtech Pharmaceuticals, Inc
N=54 --> 0 Suspended --> Terminated; FDA Clinical Hold as of 12/21/07 due to safety concerns
- trimethoprim/sulfamethoxazole / Generic mfg.
Enrollment change: DB289 Versus TMP-SMX for the Treatment of Acute Pneumocystis Jiroveci Pneumonia (PCP) (clinicaltrials.gov) - Mar 5, 2013
P3, N=48, Terminated, Sponsor: Immtech Pharmaceuticals, Inc
Suspended --> Terminated; FDA Clinical Hold as of 12/21/07 due to safety concerns N=270 --> 48
- | Trial completion: Virtual Continuity and Its Impact on Complex Hospitalized Patients' Care (clinicaltrials.gov) - Jan 28, 2013
P3, N=840, Completed, Sponsor: University of Pittsburgh
N=270 --> 48 Recruiting --> Completed
- || trimethoprim/sulfamethoxazole / Generic mfg.
New P3 trial: TriSulfa-FPI: Study to Test the Validity of the Treatment of Idiopathic Pulmonary Fibrosis With Cotrimoxazole (clinicaltrials.gov) - Jan 27, 2013
P3, N=56, Recruiting, Sponsor: Fundaci
- Trial completion, Compliance: A Study of Psychosocial and Behavioral Determinants of Differential Rates of Participant Compliance in CPCRA Protocols (clinicaltrials.gov) - Dec 16, 2012
P=N/A, N=557, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting --> Completed Active, not recruiting --> Completed
- trimethoprim/sulfamethoxazole / Generic mfg.
Trial completion: Effect of Weight and/or Obesity on Sulfamethoxazole and Trimethoprim Concentrations (clinicaltrials.gov) - Dec 12, 2012
P4, N=36, Completed, Sponsor: Texas Tech University Health Sciences Center
Active, not recruiting --> Completed Recruiting --> Completed
- || Enrollment change: Online Primary Care Physician (PCP) Training in Screening, Brief Intervention, Referral, and Treatment (clinicaltrials.gov) - Jul 22, 2012
P=N/A, N=120, Completed, Sponsor: Medical Directions, Inc
Recruiting --> Completed N=200 --> 120
- ||| Trial completion: Online Primary Care Physician (PCP) Training in Screening, Brief Intervention, Referral, and Treatment (clinicaltrials.gov) - Jul 22, 2012
P=N/A, N=120, Completed, Sponsor: Medical Directions, Inc
N=200 --> 120 Not yet recruiting --> Completed
- Enrollment open: PCP-CMV: Prevalence of Pneumocystis Jirovecii and of Cytomegalovirus in Bronchial Wash Fluid of Patients Undergoing Bronchoscopy (clinicaltrials.gov) - Jan 28, 2012
P=N/A, N=300, Recruiting, Sponsor: Carmel Medical Center
Not yet recruiting --> Completed Not yet recruiting --> Recruiting
- New P1 trial: Antiretroviral Drug Interaction Study in Volunteers With HIV (clinicaltrials.gov) - Nov 22, 2011
P1, N=32, Completed, Sponsor: National Institutes of Health Clinical Center (CC)